Brain Tumor Diagnosis and Treatment Research Report 2021 – Global Market Trajectory & Analytics, 2012-2019 & 2020-2027 – ResearchAndMarkets.com | Financial Buzz

Brain Tumor Diagnosis and Treatment Research Report 2021 – Global Market Trajectory & Analytics, 2012-2019 & 2020-2027 – ResearchAndMarkets.com

The “Brain Tumor Diagnosis and Treatment – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Brain Tumor Diagnosis and Treatment Market to Reach $887.5 Million by 2027

Amid the COVID-19 crisis, the global market for Brain Tumor Diagnosis and Treatment estimated at US$537.5 Million in the year 2020, is projected to reach a revised size of US$887.5 Million by 2027, growing at a CAGR of 7.4% over the period 2020-2027.

Primary Brain Tumor, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$587.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Secondary Brain Tumor segment is readjusted to a revised 7.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $145.3 Million, While China is Forecast to Grow at 11.2% CAGR

The Brain Tumor Diagnosis and Treatment market in the U.S. is estimated at US$145.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$197 Million by the year 2027 trailing a CAGR of 11.2% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 42 Featured):

  • AstraZeneca PLC
  • Carestream Health, Inc.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/gm9exf

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!